uniQure Announces Update on U.S. Phase I/II Clinical Trial
~ AMT-130 continues to be generally well-tolerated across both dose cohorts ~ ~ Patients treated with AMT-130 show preserved function compared to baseline...
Source: globenewswire.com
Stay updated with breaking news from Total Motor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
~ AMT-130 continues to be generally well-tolerated across both dose cohorts ~ ~ Patients treated with AMT-130 show preserved function compared to baseline...
Machine learning can create fake medical images and histories that look real. They may transform research.